Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3209528
Reference Type
Journal Article
Title
Gene Therapy for Hemophilia
Author(s)
Nienhuis, AW; Nathwani, AC; Davidoff, AM
Year
2016
Is Peer Reviewed?
Yes
Journal
Human Gene Therapy
ISSN:
1043-0342
EISSN:
1557-7422
Volume
27
Issue
4
Page Numbers
305-308
Language
English
PMID
27021603
DOI
10.1089/hum.2016.018
Abstract
Adeno-associated viral vectors have been developed for the treatment of hemophilia A and B. Derivation of vector particles is achieved after multiplasmid transfection of cells that package the vector genome to yield vector particles. To date, three clinical trials have been performed for hemophilia B. The results of these trials are described. The trial that we conducted with our collaborators has yielded evidence of clinical efficacy for hemophilia B. A vector for treating hemophilia A has been developed and a clinical trial is planned.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity